ONL Therapeutics
Ann Arbor, US · 5 known investors
Biotech
Founders & leadership
DZ

David ZacksExecutive Officer
DE
David EspositoExecutive Officer, Director
CC
Constance ChangExecutive Officer
LK
Loic K CouraudDirector
WK
William K BrinkerhoffDirector
MK
Mark K HooperDirector
JK
John K FreshleyExecutive Officer, Director
DN
David N ZacksExecutive Officer, Director
AF
Aaron FletcherDirector
MS
Michal SilverbergDirector
MN
Marian NakadaDirector
BB
Bill BurnsDirector
Investors · 5
Reported raises · per SEC filings
Form D private placements$60MraisedSep 2024 · 35 investors · Biotechnology
Rule 506(b)$10MraisedMar 2024 · 35 investors · Biotechnology
Rule 506(b)$5MraisedMar 2023 · 30 investors · Biotechnology
Rule 506(b)$26.8MraisedDec 2020 · 44 investors · Biotechnology
Rule 506(b)$2MraisedOct 2020 · 3 investors · Biotechnology
Rule 506(b)$3MraisedAug 2019 · 25 investors · Biotechnology
Rule 506(b)$639KraisedSep 2018 · 14 investors · Biotechnology
Rule 506(b)$2.6MraisedMay 2017 · 19 investors · Biotechnology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.